Photo Credit: Marc Israel Sellem / POOL
View of the Israeli Leviathan gas field gas processing rig near the Israeli city of Caesarea, on January 31, 2019.

Chevron (CVX) has announced Monday that it will acquire Texas-based Noble Energy (NBL) in an all-stock transaction for $5 billion ($10.38 per share).

It’s the biggest energy deal to take place since the start of the COVID-19 pandemic, which has totally wiped out the oil industry and basically most others as well.

Advertisement




At the moment, Noble Energy is in the red for $8 billion. The total enterprise value of the transaction, once the debt is added, is $13 billion. But it doesn’t mean much in an industry where natural gas fields, new discoveries and deals between countries are the currency of skyrocketing stock buys.

By the time the ink dries, California-based Chevron will be a major player in Israel’s energy market, taking the place of Noble Energy as a partner with Delek Group (TASE: DLEKG) in operating the Tamar and Leviathan off-shore natural gas fields along Israel’s Mediterranean coast.

“Noble Energy brings low-capital, cash-generating offshore assets in Israel, strengthening Chevron’s position in the Eastern Mediterranean,” Chevron said in its release announcing the acquisition.

Israel Approves EastMed Pipeline Deal to Transport Natural Gas to Europe

“We have successfully repositioned our portfolio and executed on our strategy to improve capital efficiency and deliver shareholder value,” Noble Energy Chairman and CEO Dave Stover said in a statement on the company’s website.

The discovery and operation of the Tamar and Leviathan natural gas fields was a game-changer for Israel and for the region, but the infamous Israeli bureaucracy combined with the pesky political rebellion by the grassroots Islamist activist populations in Egypt and Jordan who fought to trash the energy deals signed with Israel by their leadership made life very difficult for the partnership.


Share this article on WhatsApp:
Advertisement

SHARE
Previous articleCOVID-19: Six ‘Types’ of Symptoms in New Study by UK Scientists
Next articleInterferon Beta is 79% Effective as Treatment for COVID-19 in Phase II Trial
Hana Levi Julian is a Middle East news analyst with a degree in Mass Communication and Journalism from Southern Connecticut State University. A past columnist with The Jewish Press and senior editor at Arutz 7, Ms. Julian has written for Babble.com, Chabad.org and other media outlets, in addition to her years working in broadcast journalism.